mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.09 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.09 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.1 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.1 |